Recent findings show that BAP1 suppresses prostate cancer progression by deubiquitinating and stabilizing PTEN, inhibiting the PI3K-AKT-mTOR pathway and suppressing trophoblastic EMT [14]. The gene discussed is PTEN; the disease is prostate cancer.